Cardiovascular Risk and Lipid Management Reimbursement Between Patients with Stage 3–5 Chronic Kidney Disease and Those with Diabetes Mellitus

International Journal of Gerontology

Volumn 11, Issue 1, 2017, Pages 51-52

  Hung, Ta Chuan ^a,b,c   Su, Cheng Huang ^a,b   Wu, Yih Jer ^a,b   Hung, Chung Lieh ^a,b   Yeh, Hung I ^a,b   Wang, Li Yu ^b  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b MACKAY MEDICAL COLLEGE   (Taiwan)

^c NURSING AND MANAGEMENT COLLEGE   (Taiwan)

Author keywords

cardiovascular risk; CKD; diabetes; lipid management

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; DIABETES MELLITUS; DIABETIC PATIENT; ESTIMATED GLOMERULAR FILTRATION RATE; FAMILY HISTORY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REIMBURSEMENT; STAGING; TAIWAN;

EID: 85010982922     PISSN: 18739598     EISSN: 1873958X     Source Type: Journal    
DOI: 10.1016/j.ijge.2016.08.001     Document Type: Article

References (4)

1. 1 Wen, C.P., Cheng, T.Y., Tsai, M.K., et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 371 (2008), 2173–2182.
2. 2 European Association for Cardiovascular Prevention & Rehabilitation, Reiner, Z., Catapano, A.L., et al. ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 32 (2011), 1769–1818.
3. 3 Rabar, S., Harker, M., O'Flynn, N., et al., Guideline Development Group. Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance. BMJ, 349, 2014, g4356.
4. 4 Hung, C.L., Wu, Y.J., Liu, C.C., et al. Rationale and design of MAGNET (Mitochondria-AGing in NorthErn Taiwan) Study: a community-based cohort investigating mitochondria-related aging and cardiovascular diseases in suburban areas of northern Taiwan. Int J Gerontol 6 (2012), 122–126.